Literature DB >> 12152787

Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4.

Kazuhiro Hashizume1, Keith L Black.   

Abstract

Bradykinin and leukotriene C4 (LTC4) have been shown to increase molecular transport across the blood-tumor barrier (BTB). The aim of this study was to quantitatively assess whether an increase in vesicular transport or opening of tight junctions was responsible for this increase in permeability. Wistar rats bearing RG2 or C6 gliomas were infused with bradykinin or LTC4 through the right carotid artery for 15 min and then perfused to achieve fixation. Prepared specimens were observed using transmission electron microscopy. Infusion of either bradykinin or LTC4 resulted in significantly increased vesicular density in capillary endothelial cells of the BTB but not in normal brain capillaries. The opening of tight junctions, assessed by determining a cleft index, was found to be greater in tumor capillaries compared to normal controls. However, neither bradykinin nor LTC4 produce variations in the cleft index. A significant accumulation of horseradish peroxidase was seen in the intercellular peri-capillary spaces and in endothelial transport vesicles after infusion of bradykinin, demonstrating that the formation of vesicles was associated with macromolecular transcytosis. These findings suggest that pinocytotic vesicular transport is the primary means by which luminal to abluminal transport occurs in response to vasomodulation with bradykinin or LTC4.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12152787     DOI: 10.1093/jnen/61.8.725

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

Review 1.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

2.  PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.

Authors:  Keith L Black; Dali Yin; John M Ong; Jinwei Hu; Bindu M Konda; Xiao Wang; MinHee K Ko; Jennifer-Ann Bayan; Manuel R Sacapano; Andreas Espinoza; Dwain K Irvin; Yan Shu
Journal:  Brain Res       Date:  2008-07-14       Impact factor: 3.252

Review 3.  Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy.

Authors:  Eain M Cornford; Shigeyo Hyman
Journal:  NeuroRx       Date:  2005-01

4.  Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.

Authors:  Margaret Folaron; Mukund Seshadri
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

5.  Bradykinin shifts endothelial fluid passage from para- to transcellular routes.

Authors:  C Riethmüller; P Jungmann; J Wegener; H Oberleithner
Journal:  Pflugers Arch       Date:  2006-09-19       Impact factor: 3.657

6.  Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.

Authors:  Li-bo Liu; Yi-xue Xue; Yun-hui Liu
Journal:  J Neurooncol       Date:  2010-02-10       Impact factor: 4.130

7.  Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy.

Authors:  Chaoling Dong; E Scott Helton; Ping Zhou; Xuan Ouyang; Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo; Eroboghene E Ubogu
Journal:  Tissue Barriers       Date:  2018-09-05

8.  Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.

Authors:  Chun-yi Xia; Zhen Zhang; Yi-xue Xue; Ping Wang; Yun-hui Liu
Journal:  J Neurooncol       Date:  2009-02-22       Impact factor: 4.130

9.  Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.

Authors:  Jinwei Hu; Julia Y Ljubimova; Satoshi Inoue; Bindu Konda; Rameshwar Patil; Hui Ding; Andres Espinoza; Kolja A Wawrowsky; Chirag Patil; Alexander V Ljubimov; Keith L Black
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

10.  Bradykinin does not induce gap formation between human endothelial cells.

Authors:  Pia Jungmann; Marianne Wilhelmi; Hans Oberleithner; Christoph Riethmüller
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.